109 related articles for article (PubMed ID: 17094491)
1. Effects of serum on (-)-gossypol-suppressed growth in human prostate cancer cells.
Huang YW; Wang LS; Chang HL; Ye W; Sugimoto Y; Dowd MK; Wan PJ; Lin YC
Anticancer Res; 2006; 26(5A):3613-20. PubMed ID: 17094491
[TBL] [Abstract][Full Text] [Related]
2. The inhibitory effects of gossypol on human prostate cancer cells-PC3 are associated with transforming growth factor beta1 (TGFbeta1) signal transduction pathway.
Jiang J; Sugimoto Y; Liu S; Chang HL; Park KY; Kulp SK; Lin YC
Anticancer Res; 2004; 24(1):91-100. PubMed ID: 15015581
[TBL] [Abstract][Full Text] [Related]
3. Molecular mechanisms of (-)-gossypol-induced apoptosis in human prostate cancer cells.
Huang YW; Wang LS; Chang HL; Ye W; Dowd MK; Wan PJ; Lin YC
Anticancer Res; 2006; 26(3A):1925-33. PubMed ID: 16827126
[TBL] [Abstract][Full Text] [Related]
4. Direct modulation of rheumatoid inflammatory mediator expression in retinoblastoma protein-dependent and -independent pathways by cyclin-dependent kinase 4/6.
Nonomura Y; Nagasaka K; Hagiyama H; Sekine C; Nanki T; Tamamori-Adachi M; Miyasaka N; Kohsaka H
Arthritis Rheum; 2006 Jul; 54(7):2074-83. PubMed ID: 16802342
[TBL] [Abstract][Full Text] [Related]
5. Gossypol inhibits the growth of MAT-LyLu prostate cancer cells by modulation of TGFbeta/Akt signaling.
Jiang J; Ye W; Lin YC
Int J Mol Med; 2009 Jul; 24(1):69-75. PubMed ID: 19513537
[TBL] [Abstract][Full Text] [Related]
6. Androgen Receptor-Mediated Growth Suppression of HPr-1AR and PC3-Lenti-AR Prostate Epithelial Cells.
Kim YC; Chen C; Bolton EC
PLoS One; 2015; 10(9):e0138286. PubMed ID: 26372468
[TBL] [Abstract][Full Text] [Related]
7. Indole-3-carbinol (I3C) induced cell growth inhibition, G1 cell cycle arrest and apoptosis in prostate cancer cells.
Chinni SR; Li Y; Upadhyay S; Koppolu PK; Sarkar FH
Oncogene; 2001 May; 20(23):2927-36. PubMed ID: 11420705
[TBL] [Abstract][Full Text] [Related]
8. Bone morphogenetic protein-2 induces hypophosphorylation of Rb protein and repression of E2F in androgen-treated LNCaP human prostate cancer cells.
Tomari K; Kumagai T; Shimizu T; Takeda K
Int J Mol Med; 2005 Feb; 15(2):253-8. PubMed ID: 15647840
[TBL] [Abstract][Full Text] [Related]
9. Protective role of a novel erythrocyte-derived depressing factor on blood vessels of renovascular hypertensive rats.
Pang H; Wen YY; Ma N; Wang YT; Shi L
Clin Exp Pharmacol Physiol; 2007; 34(5-6):393-8. PubMed ID: 17439406
[TBL] [Abstract][Full Text] [Related]
10. Establishment and characterization of androgen-independent human prostate cancer cell lines, LN-REC4 and LNCaP-SF, from LNCaP.
Iwasa Y; Mizokami A; Miwa S; Koshida K; Namiki M
Int J Urol; 2007 Mar; 14(3):233-9. PubMed ID: 17430262
[TBL] [Abstract][Full Text] [Related]
11. TGF-beta-mediated cell cycle arrest of HPV16-immortalized human ectocervical cells correlates with decreased E6/E7 mRNA and increased p53 and p21(WAF-1) expression.
Rorke EA; Zhang D; Choo CK; Eckert RL; Jacobberger JW
Exp Cell Res; 2000 Aug; 259(1):149-57. PubMed ID: 10942587
[TBL] [Abstract][Full Text] [Related]
12. Ginsenoside Rh2 induces cell cycle arrest and differentiation in human leukemia cells by upregulating TGF-β expression.
Chung KS; Cho SH; Shin JS; Kim DH; Choi JH; Choi SY; Rhee YK; Hong HD; Lee KT
Carcinogenesis; 2013 Feb; 34(2):331-40. PubMed ID: 23125221
[TBL] [Abstract][Full Text] [Related]
13. Gossypol inhibition of mitosis, cyclin D1 and Rb protein in human mammary cancer cells and cyclin-D1 transfected human fibrosarcoma cells.
Ligueros M; Jeoung D; Tang B; Hochhauser D; Reidenberg MM; Sonenberg M
Br J Cancer; 1997; 76(1):21-8. PubMed ID: 9218727
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of cyclin D1 alters cdk 4- and cdk 2-specific phosphorylation of retinoblastoma protein.
Yu B; Lane ME; Pestell RG; Albanese C; Wadler S
Mol Cell Biol Res Commun; 2000 Jun; 3(6):352-9. PubMed ID: 11032757
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of transforming growth factor (TGF) beta1 type II receptor restores TGF-beta1 sensitivity and signaling in human prostate cancer cells.
Guo Y; Kyprianou N
Cell Growth Differ; 1998 Feb; 9(2):185-93. PubMed ID: 9486855
[TBL] [Abstract][Full Text] [Related]
16. The (-)-enantiomer of gossypol possesses higher anticancer potency than racemic gossypol in human breast cancer.
Liu S; Kulp SK; Sugimoto Y; Jiang J; Chang HL; Dowd MK; Wan P; Lin YC
Anticancer Res; 2002; 22(1A):33-8. PubMed ID: 12017312
[TBL] [Abstract][Full Text] [Related]
17. Interaction of retinoblastoma protein and D cyclins during cell-growth inhibition by hexamethylenebisacetamide in TM2H mouse epithelial cells.
Said TK; Medina D
Mol Carcinog; 1998 Jun; 22(2):128-43. PubMed ID: 9655257
[TBL] [Abstract][Full Text] [Related]
18. Differential requirements for ras and the retinoblastoma tumor suppressor protein in the androgen dependence of prostatic adenocarcinoma cells.
Fribourg AF; Knudsen KE; Strobeck MW; Lindhorst CM; Knudsen ES
Cell Growth Differ; 2000 Jul; 11(7):361-72. PubMed ID: 10939590
[TBL] [Abstract][Full Text] [Related]
19. PTHrP signaling targets cyclin D1 and induces osteoblastic cell growth arrest.
Datta NS; Chen C; Berry JE; McCauley LK
J Bone Miner Res; 2005 Jun; 20(6):1051-64. PubMed ID: 15883646
[TBL] [Abstract][Full Text] [Related]
20. Antiproliferative effect of 1alpha,25-dihydroxyvitamin D3 in human prostate cancer cell line LNCaP involves reduction of cyclin-dependent kinase 2 activity and persistent G1 accumulation.
Zhuang SH; Burnstein KL
Endocrinology; 1998 Mar; 139(3):1197-207. PubMed ID: 9492054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]